Stay updated on Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a new page build. The change reflects release metadata rather than content updates to the study record.
    Difference
    0.1%
    Check dated 2026-05-15T05:49:57.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The record history page shows a new revision label (v3.5.3) replacing the previous v3.5.2, indicating a fresh release of the page's UI and metadata. This is a metadata update rather than a change to study content.
    Difference
    0.1%
    Check dated 2026-04-30T18:44:08.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added and the previous revision v3.5.0 was removed from the history.
    Difference
    0.1%
    Check dated 2026-04-16T11:10:31.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and Revision v3.4.3 was removed from the record history.
    Difference
    0.1%
    Check dated 2026-03-18T18:19:03.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    A new Revision: v3.4.3 entry was added to the history, and the previous Revision: v3.4.2 entry was removed.
    Difference
    0.1%
    Check dated 2026-03-11T16:51:36.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 has been added, and earlier entries including a government-funding notice and Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T01:52:50.000Z thumbnail image

Stay in the know with updates to Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.